One-Year Effectiveness Study of Intravitreously Administered Conbercept^® Monotherapy in Diabetic Macular Degeneration: A Systematic Review and Meta-Analysis.

ABSTRACT:

Introduction

The evidence on efficacy of intravitreously administered Conbercept (IVC) monotherapy for diabetic macular degeneration was still limited.

Methods

A systematic review was conducted in November 2019 to summarize the current evidence on visual acuity (VA) changes with IVC monotherapy in the treatment of diabetic macular edema (DME) from Pubmed, ClinicalTrials.gov, EMbase, China National Knowledge Infrastructure (CNKI), Wanfang Database, Chin VIP Information (VIP), and Chinese Biomedical Database (CBM). Retrospective or prospective clinical studies which used IVC injection for the treatment of DME were included. Outcomes included in the analysis were change in best-corrected visual acuity (BCVA) and central macular thickness (CMT). A meta-regression was conducted t

SUBMITTER: Wang H 

PROVIDER: S-EPMC7192996 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature